Sign up USA
Proactive Investors - Run By Investors For Investors

WeedMD looking at planting first crop over the next month as first phase greenhouse expansion nearly complete

The medical cannabis firm said the first phase of construction was nearly complete
WeedMD looking at planting first crop over the next month as first phase greenhouse expansion nearly complete
The first phase (not pictured) is nearly complete

WeedMD Inc (CVE:WMD, OTC:WDDMF) expects to plant its first crop over the next month as the expansion of its state-of-the-art 14-acre greenhouse in Strathroy, Ontario, is well underway.

The medical cannabis firm said the first phase of construction covering 220,000 sq ft of the 610,000 sq ft facility was nearly complete.

READ: WeedMD Inc shares nudge higher as it's set to branch into pot-infused drinks

The first harvest is expected in July this year and the firm's annual production will increase from 1,500 kg to more than 21,000 kg.

"We are on solid footing with a fully-funded, 15-fold production expansion well underway and I am very pleased that we remain on-track and on budget," said Bruce Dawson-Scully, the chief executive of WeedMD.

"Additionally, we are working hard on patient and seniors' care outreach and engagement programs in addition to launching our strategy for capturing the adult-use market that is expected to significantly increase demand across Canada."

Earlier this month the firm unveiled it is branching into the business of cannabis-infused beverages.

It has inked a letter of intent (LOI) with Phivida Holdings Inc (CSE:VIDA; OTC:PHVAF) to form a joint venture called Cannabis Beverages Inc (CanBev).

The second phase of the greenhouse expansion sees the firm begin to retrofit another 175,000 sq ft of space, which will result in additional annual production of 12,000 kg.

This will increase the production area to a total of 395,000 sq ft and the company's annual production to more than 33,000 kg.

Option to purchase further land

The greenhouse will be the main supply source for the group's medical cannabis patients, ongoing wholesale supply to other licensed cannabis producers, and future adult-use consumers across Canada, in addition to emerging international markets.

Also today, the firm revealed it had exercised its option to purchase its original 26,000 sq ft production site in Aylmer, Ontario.

WeedMD also has the option to buy an additional four acres of adjacent land to its existing property.

This would bring the total footprint to eight acres and enable WeedMD to expand its indoor operations from 26,000 sq ft to more than 220,000 sq ft.

Shares in Toronto advanced 4.62% to C$2.04 each.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full WMD profile View Profile

WeedMD Inc. Timeline

Related Articles

August 28 2018
Tidal Royalty provides capital to help grow licenced US cannabis firms in exchange for receiving a percentage of future top-line revenues.
October 10 2018
Management behind ICC International Cannabis Corp has a clear buy, build and sell strategy

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright ©, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use